Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
148.21
+12.01 (8.82%)
At close: Jun 26, 2026, 4:00 PM EDT
150.99
+2.78 (1.88%)
After-hours: Jun 26, 2026, 7:37 PM EDT
Palvella Therapeutics Market Cap
Palvella Therapeutics has a market cap or net worth of $2.13 billion as of June 26, 2026. Its market cap has increased by 659.39% in one year.
Market Cap
2.13B
Enterprise Value
1.88B
1-Year Change
659.39%
Ranking
Category
Stock Price
$148.21
Market Cap Chart
Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $2.13B, an increase of 1,376.53%. That is a compound annual growth rate of 483.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 2.13B | 71.58% |
| Dec 31, 2025 | 1.24B | 820.07% |
| Dec 31, 2024 | 134.66M | -6.47% |
| Dec 16, 2024 | 143.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kodiak Sciences | 2.24B |
| Aurinia Pharmaceuticals | 2.22B |
| Ocular Therapeutix | 2.15B |
| Nektar Therapeutics | 2.15B |
| Generate Biomedicines | 2.11B |
| Kardigan | 2.11B |
| Precigen | 2.09B |
| Harmony Biosciences Holdings | 2.05B |